Bayer is considering halting sales of its Roundup weedkiller in the U.S. unless stronger legal protections are provided against liability claims, according to sources close to the matter. The company has already spent around $10 billion settling claims that its glyphosate-based product causes cancer, and tens of thousands of cases remain unsettled.
About the Author
